Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-20-000136
Filing Date
2020-02-14
Accepted
2020-02-14 13:58:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 zafgen13ga2019.htm SC 13G/A 46506
  Complete submission text file 0000935836-20-000136.txt   48047
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 20617721
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A